Disparity in the Use of Adjuvant Radioactive Iodine Ablation Among High-Risk Thyroid Cancer Patients

被引：0
|
作者：
Moten, A. S. [1 ]
Zhao, H. [2 ]
Willis, A. I. [3 ]
机构：
[1] Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA
[2] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA
[3] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PT97
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [1] Disparity in the use of adjuvant radioactive iodine ablation among high-risk papillary thyroid cancer patients
    Moten, Ambria S.
    Zhao, Huaqing
    Intenzo, Charles M.
    Willis, Alliric, I
    [J]. EJSO, 2019, 45 (11): : 2090 - 2095
  • [2] Adjuvant Radioactive Iodine Use Among Differentiated Thyroid Cancer Patients in the Military Health System
    Gill, Abegail A.
    Enewold, Lindsey
    Zahm, Shelia H.
    Shriver, Craig D.
    Zheng, Li
    McGlynn, Katherine A.
    Zhu, Kangmin
    [J]. MILITARY MEDICINE, 2014, 179 (09) : 1043 - 1050
  • [3] Radioactive iodine ablation in low-risk thyroid cancer
    Hindie, Elif
    Taieeb, David
    Avram, Anca M.
    Giovanella, Luca
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (09): : 686 - 686
  • [4] The benefits of radioactive iodine ablation for patients with intermediate-risk papillary thyroid cancer
    Wang, Xiaofei
    Zhu, Jingqiang
    Li, Zhihui
    Wei, Tao
    [J]. PLOS ONE, 2020, 15 (06):
  • [5] Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)
    Ho, Alan L.
    Dedecjus, Marek
    Wirth, Lori J.
    Tuttle, R. Michael
    Inabnet, William B., III
    Tennvall, Jan
    Vaisman, Fernanda
    Bastholt, Lars
    Gianoukakis, Andrew G.
    Rodien, Patrice
    Paschke, Ralf
    Elisei, Rossella
    Viola, David
    So, Karen
    Carroll, Danielle
    Hovey, Tina
    Thakre, Bhavana
    Fagin, James A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (17) : 1870 - +
  • [6] Use of Radioactive Iodine for Thyroid Cancer
    Haymart, Megan R.
    Banerjee, Mousumi
    Stewart, Andrew K.
    Koenig, Ronald J.
    Birkmeyer, John D.
    Griggs, Jennifer J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (07): : 721 - 728
  • [7] THE USE OF RADIOACTIVE IODINE IN CANCER OF THE THYROID
    SONENBERG, M
    RALL, JE
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 1956, 40 (03) : 821 - 836
  • [8] The Impact of Socioeconomic Status on the Use of Adjuvant Radioactive Iodine for Papillary Thyroid Cancer
    Zevallos, J. P.
    Yiu, Y.
    Xu, L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 520 - 520
  • [9] The Impact of Socioeconomic Status on the Use of Adjuvant Radioactive Iodine for Papillary Thyroid Cancer
    Zevallos, Jose P.
    Xu, Li
    Yiu, Yin
    [J]. THYROID, 2014, 24 (04) : 758 - 763
  • [10] Decision Variables for the Use of Radioactive Iodine in Patients with Thyroid Cancer at Intermediate Risk of Recurrence
    Newman, Samantha K.
    Patrizio, Armando
    Boucai, Laura
    [J]. CANCERS, 2024, 16 (17)
12345